The non-complete inhibition of the receptor may be viewed as a positive aspect, since complete antagonism, such as that achieved by NGF monoclonal antibodies in osteoarthritis, is associated with negative consequences due to the disruption of bone remodeling with consequent worsening of osteoarthritis [18]. Here, NGF is linked to osteoarthritis.